Report cover image

Anthelmintic Drugs Market by Drug Class (Benzimidazoles, Piperazine), Route of Administration (Injectable, Oral), Target Pathogen, Application, Distribution Channel - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 16, 2024
Length 186 Pages
SKU # IRE18418355

Description

Anthelmintic Drugs Market by Drug Class (Benzimidazoles, Piperazine), Route of Administration (Injectable, Oral), Target Pathogen, Application, Distribution Channel - Global Forecast 2024-2030


The Anthelmintic Drugs Market size was estimated at USD 3.30 billion in 2023 and expected to reach USD 3.57 billion in 2024, at a CAGR 8.02% to reach USD 5.68 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anthelmintic Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anthelmintic Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anthelmintic Drugs Market, highlighting leading vendors and their innovative profiles. These include Aden Healthcare, Anikem Laboratories, Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cipla Limited, Dechra Pharmaceuticals PLC, Dr.Reddys Laboratories Inc., Edenbridge Pharmaceuticals LLC, GlaxoSmithKline PLC, Green Cross Remedies, Healthy Life Pharma Private Limited, Johnson & Johnson Services, Inc., Kosher Pharmaceuticals, Lineage Therapeutics Inc, Lupin Limited, Mankind Pharma Ltd., McKesson Corporation, Merck & Co., Inc., Norbrook Laboratories Limited, Novartis AG, Sankur Pharmaceuticals Pvt. Ltd, Takeda Pharmaceutical Company Limited, and Virbac S.A..

Market Segmentation & Coverage

This research report categorizes the Anthelmintic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Class

Benzimidazoles
  • Piperazine
  • Route of Administration

    Injectable
  • Oral
  • Target Pathogen

    Ancylostoma Duodenale
  • Ascaris Lumbricoides
  • Enterobius Vermicularis
  • Trichuris Trichiura
  • Application

    Animal
  • Human

    Gastrointestinal Infections
  • Parenchymal Neurocysticercosis
  • Distribution Channel

    Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Veterinary Hospitals & Clinics
  • Veterinary Pharmacies
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Anthelmintic Drugs Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anthelmintic Drugs Market?
    3. What are the technology trends and regulatory frameworks in the Anthelmintic Drugs Market?
    4. What is the market share of the leading vendors in the Anthelmintic Drugs Market?
    5. Which modes and strategic moves are suitable for entering the Anthelmintic Drugs Market?


    Note: PDF & Excel + Online Access - 1 Year

    • Table of Contents

    186 Pages
    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Anthelmintic Drugs Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Growing pet adoption coupled with rising focus towards maintaining animal
    health
    5.1.1.2. Increasing spending for animal healthcare and wellness
    5.1.1.3. Accelerating prevalence of helminthic infections
    5.1.2. Restraints
    5.1.2.1. High cost of antiparasitic drugs
    5.1.3. Opportunities
    5.1.3.1. Increasing veterinary healthcare services centers
    5.1.3.2. Emergence of anthelmintic drugs as immune modulators in cancer
    5.1.4. Challenges
    5.1.4.1. Concerns about the development of drug resistance
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Anthelmintic Drugs Market, by Drug Class
    6.1. Introduction
    6.2. Benzimidazoles
    6.3. Piperazine
    7. Anthelmintic Drugs Market, by Route of Administration
    7.1. Introduction
    7.2. Injectable
    7.3. Oral
    8. Anthelmintic Drugs Market, by Target Pathogen
    8.1. Introduction
    8.2. Ancylostoma Duodenale
    8.3. Ascaris Lumbricoides
    8.4. Enterobius Vermicularis
    8.5. Trichuris Trichiura
    9. Anthelmintic Drugs Market, by Application
    9.1. Introduction
    9.2. Animal
    9.3. Human
    9.4.1. Gastrointestinal Infections
    9.4.2. Parenchymal Neurocysticercosis
    10. Anthelmintic Drugs Market, by Distribution Channel
    10.1. Introduction
    10.2. Hospital Pharmacies
    10.3. Online Pharmacies
    10.4. Retail Pharmacies
    10.5. Veterinary Hospitals & Clinics
    10.6. Veterinary Pharmacies
    11. Americas Anthelmintic Drugs Market
    11.1. Introduction
    11.2. Argentina
    11.3. Brazil
    11.4. Canada
    11.5. Mexico
    11.6. United States
    12. Asia-Pacific Anthelmintic Drugs Market
    12.1. Introduction
    12.2. Australia
    12.3. China
    12.4. India
    12.5. Indonesia
    12.6. Japan
    12.7. Malaysia
    12.8. Philippines
    12.9. Singapore
    12.10. South Korea
    12.11. Taiwan
    12.12. Thailand
    12.13. Vietnam
    13. Europe, Middle East & Africa Anthelmintic Drugs Market
    13.1. Introduction
    13.2. Denmark
    13.3. Egypt
    13.4. Finland
    13.5. France
    13.6. Germany
    13.7. Israel
    13.8. Italy
    13.9. Netherlands
    13.10. Nigeria
    13.11. Norway
    13.12. Poland
    13.13. Qatar
    13.14. Russia
    13.15. Saudi Arabia
    13.16. South Africa
    13.17. Spain
    13.18. Sweden
    13.19. Switzerland
    13.20. Turkey
    13.21. United Arab Emirates
    13.22. United Kingdom
    14. Competitive Landscape
    14.1. FPNV Positioning Matrix
    14.2. Market Share Analysis, By Key Player
    14.3. Competitive Scenario Analysis, By Key Player
    15. Competitive Portfolio
    15.1. Key Company Profiles
    15.1.1. Aden Healthcare
    15.1.2. Anikem Laboratories
    15.1.3. Bayer AG
    15.1.4. Boehringer Ingelheim International GmbH
    15.1.5. Ceva Sante Animale
    15.1.6. Cipla Limited
    15.1.7. Dechra Pharmaceuticals PLC
    15.1.8. Dr.Reddys Laboratories Inc.
    15.1.9. Edenbridge Pharmaceuticals LLC
    15.1.10. GlaxoSmithKline PLC
    15.1.11. Green Cross Remedies
    15.1.12. Healthy Life Pharma Private Limited
    15.1.13. Johnson & Johnson Services, Inc.
    15.1.14. Kosher Pharmaceuticals
    15.1.15. Lineage Therapeutics Inc
    15.1.16. Lupin Limited
    15.1.17. Mankind Pharma Ltd.
    15.1.18. McKesson Corporation
    15.1.19. Merck & Co., Inc.
    15.1.20. Norbrook Laboratories Limited
    15.1.21. Novartis AG
    15.1.22. Sankur Pharmaceuticals Pvt. Ltd
    15.1.23. Takeda Pharmaceutical Company Limited
    15.1.24. Virbac S.A.
    15.2. Key Product Portfolio
    16. Appendix
    16.1. Discussion Guide
    16.2. License & Pricing
    FIGURE 1. ANTHELMINTIC DRUGS MARKET RESEARCH PROCESS
    FIGURE 2. ANTHELMINTIC DRUGS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ANTHELMINTIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ANTHELMINTIC DRUGS MARKET DYNAMICS
    FIGURE 7. ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
    FIGURE 8. ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
    FIGURE 10. ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2023 VS 2030 (%)
    FIGURE 12. ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    FIGURE 14. ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
    FIGURE 16. ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 20. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 22. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 25. ANTHELMINTIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 26. ANTHELMINTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us